Harmony Biosciences

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$200,489
$184,733
$201,267
$186,038
Gross Profit
162,336
152,739
146,858
143,260
EBITDA
59,250
66,981
66,332
72,486
EBIT
53,283
61,013
60,364
66,518
Net Income
39,776
45,560
49,475
46,093
Net Change In Cash
200,489
184,733
201,267
186,038
Free Cash Flow
79,323
33,859
75,049
70,498
Cash
546,050
488,998
453,001
387,367
Basic Shares
58,427
58,525
58,218
58,104

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$714,734
$582,022
$437,855
$305,440
Gross Profit
557,919
460,786
354,374
249,922
EBITDA
233,412
221,512
143,571
106,368
EBIT
209,300
197,153
120,186
87,528
Net Income
145,493
128,853
181,468
34,597
Net Change In Cash
714,734
582,022
437,855
305,440
Cost of Revenue
9,475
5,678
Free Cash Flow
218,668
219,075
104,294
-1,741
Cash
453,001
311,660
243,784
234,309
Basic Shares
57,870
60,372
61,097
59,205

Earnings Calls

Quarter EPS
2025-06-30
$0.92
2025-03-31
$0.77
2024-12-31
$1.08
2024-09-30
$0.79